| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/01/2010 | CA2747965A1 Novel antibacterial agents for the treatment of gram positive infections |
| 07/01/2010 | CA2747686A1 C1orf59 peptides and vaccines including the same |
| 06/30/2010 | EP2201897A2 Tumor targeted photodiagnostic-phototherapeutic agents |
| 06/30/2010 | EP2201034A1 Neuroprotection using nap-like and sal-like peptide mimetics |
| 06/30/2010 | EP2201026A1 Novel p2x7 epitopes |
| 06/30/2010 | EP2201025A1 Functional lipid constructs |
| 06/30/2010 | EP2201024A1 Peptides inducing a cd4i conformation in hiv gp120 while retaining vacant cd4 binding site |
| 06/30/2010 | CN101759780A Soluble liver antigen T cell epitope and detection kit prepared thereof |
| 06/30/2010 | CN101759779A Active spider polypeptide, preparation method and application thereof |
| 06/30/2010 | CN101759778A Active spider polypeptide, preparation method and application thereof |
| 06/30/2010 | CN101759777A Method for synthesizing goserelin |
| 06/30/2010 | CN101759776A Method for synthesizing eptifibatide |
| 06/30/2010 | CN101210044B Polypeptide and application thereof |
| 06/29/2010 | US7745578 a mixture of a heat shock protein and a carrier, used to promote migration of cells from stents and specific sites including sites of inflammation, infection, an autoimmune reaction, a tumor and a transplanted organ or tissue |
| 06/29/2010 | US7745577 cyclic peptide having amino acid sequences amidated or hydroxylated at the carboxy terminus and conjugated to a detectible agent and/or a cytotoxic agent, used for detecting tumors and preventing transformation of normal cells into tumor cells |
| 06/29/2010 | US7745576 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 06/29/2010 | US7745573 Conotoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides |
| 06/29/2010 | US7745572 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 06/29/2010 | US7745570 PH dependent adhesive peptides |
| 06/29/2010 | US7745444 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 06/29/2010 | US7745412 converting an agonist of protein kinase C to an antagonist of protein kinase C; amino acid sequences; crosslinked via an N-terminal Cys-Cys bond to a peptide to facilitate transport cellular uptake |
| 06/29/2010 | US7745411 Treating anemia as a result of renal failure, AIDS, cancer, organ or bone marrow transplant, chemotherapy or radiotherapy using a peptide of given sequence, comprising angiotensin analogs |
| 06/29/2010 | US7745409 Polypeptide comprising the amino acid sequence Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys (SEQ ID NO:125); activating guanylate cyclase C (GC-C) receptor; gastroesophageal reflux disease, Crohn's disease, ulcerative colitis, Inflammatory bowel disease, dyspepsia, constipation |
| 06/29/2010 | US7745405 Cancer treatment by administration of a synthetic peptide comprising a sequence of amino acids within the p53 protein and a membrane penetrating leader sequence; fusion proteins for tissue-targeted therapy |
| 06/29/2010 | US7745397 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; cancer vaccines |
| 06/29/2010 | US7745395 Recombinant protease comprising prostate-specific protease cleavage site and deficient in furin cleavage site for use as therapeutic agent in treatment of cell proliferative disorders; antitumor agents |
| 06/29/2010 | US7745392 Core moiety such as 1,4,8,11-tetraazacyclotetradecane with a plurality of side chains containing guanidinium groups; conjugated to antigens, peptides, tumor antigens, anticancer agents, antimicrobials |
| 06/29/2010 | US7745142 Molecular modification assays |
| 06/29/2010 | US7744927 Methods of promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 06/29/2010 | US7744898 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 06/29/2010 | US7744896 therapeutic vaccine anti-HIV, anti-AIDS and against tumors and syndromes associated with HIV infection |
| 06/29/2010 | US7744870 A conjugated compound contains antibody or a Fab, and a radiostable therapeutic active agent; for diagnosis/therapy of colorectal cancer; biological conjugated drugs |
| 06/29/2010 | US7744853 Radiolabeled annexins |
| 06/29/2010 | CA2636421C A method of platelet and whole blood storage |
| 06/29/2010 | CA2405521C Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 06/29/2010 | CA2337969C Compound and method for the prevention and/or the treatment of allergy |
| 06/29/2010 | CA2325345C Medicaments for inducing cytotoxic t-cells |
| 06/24/2010 | WO2010071894A2 Tfpi inhibitors and methods of use |
| 06/24/2010 | WO2010071132A1 Peptide for inhibiting skin aging |
| 06/24/2010 | WO2010070877A1 Elovl7 epitope peptides and vaccines containing the same |
| 06/24/2010 | WO2010070394A1 Modulators of the cx3cr1 receptor and therapeutic uses thereof |
| 06/24/2010 | WO2010070078A1 Anticancer compounds |
| 06/24/2010 | WO2010046588A9 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates |
| 06/24/2010 | WO2010011952A3 Flip death effector domain derived peptides for inducing autophagy |
| 06/24/2010 | US20100160602 Method for predicting protein aggregation and designing aggregation inhibitors |
| 06/24/2010 | US20100160241 Novel compound having gpr54 agonistic activity |
| 06/24/2010 | US20100160239 Peptide nucleic acid based guanidinium compounds |
| 06/24/2010 | US20100160238 TGFP-CAP Peptide and its Uses |
| 06/24/2010 | US20100160234 Cell-proliferation inhibiting vpg proteins, fragments or analogs thereof and their applications |
| 06/24/2010 | US20100160231 Axmi-150 delta-endotoxin gene and methods for its use |
| 06/24/2010 | US20100160228 Method for inhibiting or stimulating angiogenesis in an individual |
| 06/24/2010 | US20100160215 Antibiotic compositions for the treatment of gram negative infections |
| 06/24/2010 | US20100160211 Glycopeptide phosphonate derivatives |
| 06/24/2010 | US20100160210 Guanidinium delivery carriers |
| 06/24/2010 | US20100160175 Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds |
| 06/24/2010 | US20100159477 Reagents for the detection of protein phosphorylation in signaling pathways |
| 06/24/2010 | US20100159006 Improved antimicrobial peptides |
| 06/24/2010 | US20100158933 Ige ch3 peptide vaccine |
| 06/24/2010 | US20100158932 Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof |
| 06/24/2010 | US20100158931 Novel immunotherapy against several tumors including neuronal and brain tumors |
| 06/24/2010 | US20100158837 Iron oxide-binding peptides |
| 06/24/2010 | US20100158822 Peptides that bind to silica-coated particles |
| 06/24/2010 | US20100158814 Fibrin-Binding Peptides and Conjugates Thereof |
| 06/24/2010 | CA2747721A1 Tfpi inhibitors and methods of use |
| 06/24/2010 | CA2745377A1 Anticancer compounds |
| 06/23/2010 | EP2198877A2 Orally administered peptides to ameliorate atherosclerosis |
| 06/23/2010 | EP2197900A2 Mutant double cyclized receptor peptides inhibiting 1-adrenoceptor antibodies |
| 06/23/2010 | EP2197899A2 Cyclic peptides comprising at least one aza- beta3-aminoacyl residue and uses thereof |
| 06/23/2010 | EP2197898A1 Protease inhibition |
| 06/23/2010 | EP2197897A1 Amino acid pairing-based self assembling peptides and methods |
| 06/23/2010 | CN101747430A Two peptides with oxidation resistant function - Fe-Alpha29 peptide-porphyrin iron and Beta13 peptide-porphyrin iron |
| 06/23/2010 | CN101747415A Rabbit anti-human MARVELD1 peptide polyclonal antibody and preparation method thereof |
| 06/23/2010 | CN101747414A Tumor necrosis factor (TNF)-alpha binding peptide and tumor necrosis factor receptor 1(TNFR1) blocking peptide and applications thereof in treatment of TNF related diseases |
| 06/23/2010 | CN101747413A Envelope glycoprotein penetrating oligopeptide or modifier/ derivative thereof with blood platelet apoptosis activity inhibiting function and application |
| 06/23/2010 | CN101747412A Synthesis and preparation process of eptifibatide |
| 06/22/2010 | US7741436 Injecting the tripeptide, Lys-Asp-Ile, derived from the neurite outgrowth-promoting domain of laminin-1, into the epidural space of the spine to regenerate the tissue |
| 06/22/2010 | US7741435 Substance P-saporin (SP-SAP) conjugates and methods of use thereof |
| 06/22/2010 | US7741431 Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof |
| 06/22/2010 | US7741297 Cpg sites; point mutations; immunogens; cancer |
| 06/22/2010 | US7741290 protein kinase C inhibitors (PKC); heart transplants |
| 06/22/2010 | US7741288 serine/threonine phosphatases (PP1); immobilization, screening |
| 06/22/2010 | US7741286 kringle peptides; peptidase stabilized |
| 06/22/2010 | US7741280 Multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 06/22/2010 | US7741274 Increasing hematopoiesis; treating glucosuria, hyperglycemia and diabetes; thrombocytopenia |
| 06/22/2010 | CA2242878C Induction of immune response against desired determinants |
| 06/17/2010 | WO2010067611A1 ANTIBODY AGAINST N-TERMINAL REGION OF β-CHAIN OF HEMOGLOBIN |
| 06/17/2010 | WO2010066740A1 Single-chain antiparallel coiled coil proteins |
| 06/17/2010 | WO2010066380A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes |
| 06/17/2010 | WO2010066125A1 A short peptide, preparation and uses thereof |
| 06/17/2010 | WO2010066010A1 Process for the preparation of asymmetrical bis(thiosemicarbazones) |
| 06/17/2010 | WO2010065995A1 Isolated vegf-c and vegf-d peptides and uses thereof |
| 06/17/2010 | WO2010047515A9 Bipodal peptide binder |
| 06/17/2010 | WO2010033240A3 Carbohydrate-based drug delivery polymers and conjugates thereof |
| 06/17/2010 | US20100152421 Sparc-derived tumor rejection antigenic peptides and medicaments comprising the same |
| 06/17/2010 | US20100152420 Peptide networks |
| 06/17/2010 | US20100152109 Influenza inhibiting compositions and methods |
| 06/17/2010 | US20100151514 substitute substance for human mucin and is useful in fields such as pharmaceutical, agricultural, and food fields; easily in large amounts from jellyfishes and is therefore superior as economical and environmental preservation techniques; accurate determination of the molecular weights |
| 06/17/2010 | US20100151494 Fret protease assays for clostridial toxins |
| 06/17/2010 | US20100151481 Cell-signaling assays |
| 06/17/2010 | US20100151096 Inhibition of ice crystal growth |